These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation. Cogo S; Ho FY; Tosoni E; Tomkins JE; Tessari I; Iannotta L; Montine TJ; Manzoni C; Lewis PA; Bubacco L; Chartier Harlin MC; Taymans JM; Kortholt A; Nichols J; Cendron L; Civiero L; Greggio E Brain Res; 2022 Mar; 1778():147781. PubMed ID: 35016853 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of ten LRRK2 variants in Parkinson's disease: A comprehensive review. Simpson C; Vinikoor-Imler L; Nassan FL; Shirvan J; Lally C; Dam T; Maserejian N Parkinsonism Relat Disord; 2022 May; 98():103-113. PubMed ID: 35654702 [TBL] [Abstract][Full Text] [Related]
11. Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity. Shu Y; Ming J; Zhang P; Wang Q; Jiao F; Tian B PLoS One; 2016; 11(3):e0149739. PubMed ID: 26930193 [TBL] [Abstract][Full Text] [Related]
12. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation. Rudenko IN; Kaganovich A; Hauser DN; Beylina A; Chia R; Ding J; Maric D; Jaffe H; Cookson MR Biochem J; 2012 Aug; 446(1):99-111. PubMed ID: 22612223 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the WD40 domain dimer of LRRK2. Zhang P; Fan Y; Ru H; Wang L; Magupalli VG; Taylor SS; Alessi DR; Wu H Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1579-1584. PubMed ID: 30635421 [TBL] [Abstract][Full Text] [Related]
14. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
16. Development of phospho-specific Rab protein antibodies to monitor Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease. Li X; Wang QJ; Pan N; Lee S; Zhao Y; Chait BT; Yue Z PLoS One; 2011 Mar; 6(3):e17153. PubMed ID: 21390248 [TBL] [Abstract][Full Text] [Related]
18. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ; Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347 [TBL] [Abstract][Full Text] [Related]
20. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes. Wang X; Bondar VV; Davis OB; Maloney MT; Agam M; Chin MY; Cheuk-Nga Ho A; Ghosh R; Leto DE; Joy D; Calvert MEK; Lewcock JW; Di Paolo G; Thorne RG; Sweeney ZK; Henry AG Elife; 2023 Oct; 12():. PubMed ID: 37874617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]